drugset / Trial / NCT00130806
An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to evaluate the effectiveness and tolerability of an investigational drug in patients with type 2 diabetes (a specific type of diabetes) who are not currently treated with insulin.
Timeline
- Start
- 2005-09
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Muraglitazar | Small molecule | — | — |